compounded semaglutide .25mg Semaglutide: Injection Home Kit – NativeMed Semaglutide for weight loss |

In this review I aim to re-examine the contested concept of food addiction as a disease in the context of emerging GLP-1based obesity pharmacotherapies, integrating perspectives from neurobiology, societal impacts, and early evidence for their potential application in other substance-use disorders

Less emotionally responsive

The most advanced program, Daewoong Therapeutics' CLOPAM platform, achieved over 80% relative bioavailability for semaglutide versus subcutaneous injection in a 70-person Phase 1 study (August 2025)

Most people have heard at least something about glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, or GLP-1s

Heart disease Large clinical trials revealed a striking finding: GLP-1 drugs reduce the risk of heart attacks, strokes and cardiovascular death